.png)
Drug-Eluting Stent Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : May 2022 Pages : 170 Category: Pharma & Healthcare Report Code : HC0511029
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Drug-Eluting Stent Market by Type (Polymer-based coating stents, Polymer-free coating stents) Application (Hospitals, Ambulatory Surgical Centers (ASCs), Cardiology Centers) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Drug-Eluting Stent Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Drug-Eluting Stent is an artificial coronary stent placed into narrowed, diseased peripheral or coronary arteries that slowly releases a drug to block cell proliferation, by this way it prevents fibrosis that, together with clots (thrombi), could otherwise block the stented artery, a process called restenosis.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
-
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Johnson and Johnson
- MicroPort Scientific Corporation
- Biotronik Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- hich are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Drug-Eluting Stent Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Polymer-based coating stents
o Polymer-free coating stents
· Drug-Eluting Stent Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Ambulatory Surgical Centers (ASCs)
o Cardiology Centers
· Drug-Eluting Stent Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott Laboratories
o Boston Scientific Corporation
o Medtronic plc
o Johnson and Johnson
o MicroPort Scientific Corporation
o Biotronik Inc
· Drug-Eluting Stent Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Drug-Eluting Stent Market, By Type
5.1. Introduction
5.2. Global Drug-Eluting Stent Revenue and Market Share by Type (2017-2021)
5.2.1. Global Drug-Eluting Stent Revenue and Revenue Share by Type (2017-2021)
5.3. Polymer-based coating stents
5.3.1. Global Polymer-based coating stents Revenue and Growth Rate (2017-2021)
5.4. Polymer-free coating stents
5.4.1. Global Polymer-free coating stents Revenue and Growth Rate (2017-2021)
6. Drug-Eluting Stent Market, By Applications
6.1. Introduction
6.2. Global Drug-Eluting Stent Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Drug-Eluting Stent Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospitals
6.3.1. Global Hospitals Revenue and Growth Rate (2017-2021)
6.4. Ambulatory Surgical Centers (ASCs)
6.4.1. Global Ambulatory Surgical Centers (ASCs) Revenue and Growth Rate (2017-2021)
6.5. Cardiology Centers
6.5.1. Global Cardiology Centers Revenue and Growth Rate (2017-2021)
7. Drug-Eluting Stent Market, By Region
7.1. Introduction
7.2. Global Drug-Eluting Stent Revenue and Market Share by Regions
7.2.1. Global Drug-Eluting Stent Revenue by Regions (2017-2021)
7.3. North America Drug-Eluting Stent by Countries
7.3.1. North America Drug-Eluting Stent Revenue and Growth Rate (2017-2021)
7.3.2. North America Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Drug-Eluting Stent by Countries
7.4.1. Europe Drug-Eluting Stent Revenue and Growth Rate (2017-2021)
7.4.2. Europe Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Drug-Eluting Stent by Countries
7.5.1. Asia-Pacific Drug-Eluting Stent Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Drug-Eluting Stent by Countries
7.6.1. South America Drug-Eluting Stent Revenue and Growth Rate (2017-2021)
7.6.2. South America Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Drug-Eluting Stent by Countries
7.7.1. Middle East and Africa Drug-Eluting Stent Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Boston Scientific Corporation
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Medtronic plc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Johnson and Johnson
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. MicroPort Scientific Corporation
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. MicroPort Scientific Corporation
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Biotronik Inc
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
9. Drug-Eluting Stent Market Forecast (2022-2027)
9.1. Global Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Drug-Eluting Stent Market Forecast by Regions (2022-2027)
9.2.1. North America Drug-Eluting Stent Market Forecast (2022-2027)
9.2.1.1. United States Drug-Eluting Stent Market Forecast (2022-2027)
9.2.1.2. Canada Drug-Eluting Stent Market Forecast (2022-2027)
9.2.1.3. Mexico Drug-Eluting Stent Market Forecast (2022-2027)
9.2.2. Europe Drug-Eluting Stent Market Forecast (2022-2027)
9.2.2.1. Germany Drug-Eluting Stent Market Forecast (2022-2027)
9.2.2.2. France Drug-Eluting Stent Market Forecast (2022-2027)
9.2.2.3. UK Drug-Eluting Stent Market Forecast (2022-2027)
9.2.2.4. Russia Drug-Eluting Stent Market Forecast (2022-2027)
9.2.2.5. Italy Drug-Eluting Stent Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Drug-Eluting Stent Market Forecast (2022-2027)
9.2.3. Asia-Pacific Drug-Eluting Stent Market Forecast (2022-2027)
9.2.3.1. China Drug-Eluting Stent Market Forecast (2022-2027)
9.2.3.2. Japan Drug-Eluting Stent Market Forecast (2022-2027)
9.2.3.3. Korea Drug-Eluting Stent Market Forecast (2022-2027)
9.2.3.4. India Drug-Eluting Stent Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Drug-Eluting Stent Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Drug-Eluting Stent Market Forecast (2022-2027)
9.2.4. South America Drug-Eluting Stent Market Forecast (2022-2027)
9.2.4.1. Brazil Drug-Eluting Stent Market Forecast (2022-2027)
9.2.4.2. Argentina Drug-Eluting Stent Market Forecast (2022-2027)
9.2.4.3. Columbia Drug-Eluting Stent Market Forecast (2022-2027)
9.2.4.4. Rest of South America Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5. Middle East and Africa Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5.3. Egypt Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5.4. Nigeria Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5.5. South Africa Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5.6. Turkey Drug-Eluting Stent Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Drug-Eluting Stent Market Forecast (2022-2027)
9.3. Drug-Eluting Stent Market Forecast by Type (2022-2027)
9.3.1. Drug-Eluting Stent Forecast by Type (2022-2027)
9.3.2. Drug-Eluting Stent Market Share Forecast by Type (2022-2027)
9.4. Drug-Eluting Stent Market Forecast by Applications (2022-2027)
9.4.1. Drug-Eluting Stent Forecast by Applications (2022-2027)
9.4.2. Drug-Eluting Stent Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Drug-Eluting Stent Revenue and Revenue Share by Type (2017-2019)
Figure Global Polymer-based coating stents Revenue and Growth Rate (2017-2019)
Figure Global Polymer-free coating stents Revenue and Growth Rate (2017-2019)
Table Global Drug-Eluting Stent Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Ambulatory Surgical Centers (ASCs) Revenue and Growth Rate (2017-2019)
Figure Global Cardiology Centers Revenue and Growth Rate (2017-2019)
Table Global Drug-Eluting Stent Revenue by Regions (2017-2019)
Figure North America Drug-Eluting Stent Growth Rate (2017-2019)
Figure North America Drug-Eluting Stent Revenue and Growth Rate (2017-2019)
Figure North America Drug-Eluting Stent by Countries (2017-2019)
Figure North America Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2019)
Figure United States Drug-Eluting Stent Growth Rate (2017-2019)
Figure United States Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Drug-Eluting Stent Growth Rate (2017-2019)
Figure Canada Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Drug-Eluting Stent Growth Rate (2017-2019)
Figure Mexico Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Drug-Eluting Stent Growth Rate (2017-2019)
Figure Europe Drug-Eluting Stent Revenue and Growth Rate (2017-2019)
Figure Europe Drug-Eluting Stent by Countries (2017-2019)
Figure Europe Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2019)
Figure Germany Drug-Eluting Stent Growth Rate (2017-2019)
Figure Germany Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Drug-Eluting Stent Growth Rate (2017-2019)
Figure France Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Drug-Eluting Stent Growth Rate (2017-2019)
Figure UK Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Drug-Eluting Stent Growth Rate (2017-2019)
Figure Russia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Drug-Eluting Stent Growth Rate (2017-2019)
Figure Italy Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Drug-Eluting Stent Growth Rate (2017-2019)
Figure Rest of Europe Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Drug-Eluting Stent Growth Rate (2017-2019)
Figure Asia-Pacific Drug-Eluting Stent Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Drug-Eluting Stent by Countries (2017-2019)
Figure Asia-Pacific Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2019)
Figure China Drug-Eluting Stent Growth Rate (2017-2019)
Figure China Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Drug-Eluting Stent Growth Rate (2017-2019)
Figure Japan Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Drug-Eluting Stent Growth Rate (2017-2019)
Figure Korea Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Drug-Eluting Stent Growth Rate (2017-2019)
Figure India Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Drug-Eluting Stent Growth Rate (2017-2019)
Figure Southeast Asia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Drug-Eluting Stent Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Drug-Eluting Stent Growth Rate (2017-2019)
Figure South America Drug-Eluting Stent Revenue and Growth Rate (2017-2019)
Figure South America Drug-Eluting Stent by Countries (2017-2019)
Figure South America Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Drug-Eluting Stent Growth Rate (2017-2019)
Figure Brazil Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Drug-Eluting Stent Growth Rate (2017-2019)
Figure Argentina Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Drug-Eluting Stent Growth Rate (2017-2019)
Figure Columbia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Drug-Eluting Stent Growth Rate (2017-2019)
Figure Rest of South America Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Drug-Eluting Stent Growth Rate (2017-2019)
Figure Middle East and Africa Drug-Eluting Stent Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Drug-Eluting Stent by Countries (2017-2019)
Figure Middle East and Africa Drug-Eluting Stent Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Drug-Eluting Stent Growth Rate (2017-2019)
Figure Saudi Arabia Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Drug-Eluting Stent Growth Rate (2017-2019)
Figure United Arab Emirates Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Drug-Eluting Stent Growth Rate (2017-2019)
Figure Egypt Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Drug-Eluting Stent Growth Rate (2017-2019)
Figure Nigeria Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Drug-Eluting Stent Growth Rate (2017-2019)
Figure South Africa Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Drug-Eluting Stent Growth Rate (2017-2019)
Figure Turkey Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Drug-Eluting Stent Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott Laboratories Drug-Eluting Stent Financial Overview
Table Boston Scientific Corporation Drug-Eluting Stent Financial Overview
Table Medtronic plc Drug-Eluting Stent Financial Overview
Table Johnson and Johnson Drug-Eluting Stent Financial Overview
Table MicroPort Scientific Corporation Drug-Eluting Stent Financial Overview
Table MicroPort Scientific Corporation Drug-Eluting Stent Financial Overview
Table Biotronik Inc Drug-Eluting Stent Financial Overview
Figure Global Drug-Eluting Stent Revenue (Millions USD) and Growth Rate (2019-2027)
Table Drug-Eluting Stent Market Forecast by Regions (2019-2027)
Figure North America Drug-Eluting Stent Market Forecast (2019-2027)
Figure United States Drug-Eluting Stent Market Forecast (2019-2027)
Figure Canada Drug-Eluting Stent Market Forecast (2019-2027)
Figure Mexico Drug-Eluting Stent Market Forecast (2019-2027)
Figure Europe Drug-Eluting Stent Market Forecast (2019-2027)
Figure Germany Drug-Eluting Stent Market Forecast (2019-2027)
Figure France Drug-Eluting Stent Market Forecast (2019-2027)
Figure UK Drug-Eluting Stent Market Forecast (2019-2027)
Figure Russia Drug-Eluting Stent Market Forecast (2019-2027)
Figure Italy Drug-Eluting Stent Market Forecast (2019-2027)
Figure Rest of Europe Drug-Eluting Stent Market Forecast (2019-2027)
Figure Asia-Pacific Drug-Eluting Stent Market Forecast (2019-2027)
Figure China Drug-Eluting Stent Market Forecast (2019-2027)
Figure Japan Drug-Eluting Stent Market Forecast (2019-2027)
Figure Korea Drug-Eluting Stent Market Forecast (2019-2027)
Figure India Drug-Eluting Stent Market Forecast (2019-2027)
Figure Southeast Asia Drug-Eluting Stent Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Drug-Eluting Stent Market Forecast (2019-2027)
Figure South America Drug-Eluting Stent Market Forecast (2019-2027)
Figure Brazil Drug-Eluting Stent Market Forecast (2019-2027)
Figure Argentina Drug-Eluting Stent Market Forecast (2019-2027)
Figure Columbia Drug-Eluting Stent Market Forecast (2019-2027)
Figure Rest of South America Drug-Eluting Stent Market Forecast (2019-2027)
Figure Middle East and Africa Drug-Eluting Stent Market Forecast (2019-2027)
Figure Saudi Arabia Drug-Eluting Stent Market Forecast (2019-2027)
Figure United Arab Emirates Drug-Eluting Stent Market Forecast (2019-2027)
Figure Egypt Drug-Eluting Stent Market Forecast (2019-2027)
Figure Nigeria Drug-Eluting Stent Market Forecast (2019-2027)
Figure South Africa Drug-Eluting Stent Market Forecast (2019-2027)
Figure Turkey Drug-Eluting Stent Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Drug-Eluting Stent Market Forecast (2019-2027)
Figure Global Drug-Eluting Stent Forecast by Type (2019-2027)
Figure Global Drug-Eluting Stent Market Share Forecast by Type (2019-2027)
Figure Global Drug-Eluting Stent Forecast by Type (2019-2027)
Figure Global Drug-Eluting Stent Forecast by Applications (2019-2027)
Figure Global Drug-Eluting Stent Market Share Forecast by Applications (2019-2027)
Figure Global Drug-Eluting Stent Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|